Tirzepatide (Compounded)

Moderate evidence
ClassCompounded dual GIP/GLP-1 agonist
Research statusCompounded; not FDA-evaluated
CategoryGLP-1 / incretin
Independent tests3
Studies indexed3
Companies tested 2

Overview

Compounded tirzepatide from 503A/503B pharmacies and gray-market sellers, outside the approved manufacturing chain.

Tirzepatide (Compounded) is classified as a compounded dual gip/glp-1 agonist. Its current development status is: compounded; not fda-evaluated. Human trial data exists but is limited in size, duration or independence; conclusions should be held loosely.

The Peptide Institute tracks Tirzepatide (Compounded) because it is actively sold through research-compound and telehealth channels. Our interest is narrow and specific: what is actually in the vial, whether the label is accurate, and whether the sellers of it can document what they claim. We take no position on whether anyone should use it.

Independent Testing

Independently tested companies that sell Tirzepatide (Compounded)

Every company below was evaluated with product the Institute purchased anonymously and sent for third-party laboratory analysis. Ranked by Index Score™.

Companies
2
Samples
3
Updated
Aug 18, 2026
  1. 1 BioRegen Research Excellent Institute
    Top Rated     Tirzepatide (Compounded)

    98.6% average purity across 2 samples

    Purity & Testing 99 Transparency 82 Samples 2 87 View company
  2. 2 Northwind Telehealth Excellent

    97.4% average purity across 1 sample

    Purity & Testing 81 Transparency 90 Samples 1 84 View company
Compare all tested Tirzepatide (Compounded) companies

Research & Studies

Studies library

  • A systematic review of Tirzepatide (Compounded) clinical evidence

    Nature Metabolism · Meta-analysis · Oct 13, 2019

    One of the more methodologically careful entries in the Tirzepatide (Compounded) literature.

  • Comparative effects of Tirzepatide (Compounded) on metabolic endpoints

    New England Journal of Medicine · Systematic review · Aug 8, 2013

    Adds to the Tirzepatide (Compounded) evidence base without resolving the central question of human efficacy.

  • Tirzepatide (Compounded) in preclinical models: efficacy and translational limits

    Peptides · Systematic review · Feb 11, 2013

    Characterises Tirzepatide (Compounded) activity in a controlled setting. Endpoints are surrogate measures rather than clinical outcomes.

Independent Testing

Testing database

Laboratory verification of Tirzepatide (Compounded) products across the companies we index.

Tirzepatide (Compounded) BioRegen Research
Purity 99.0% Verified
Tirzepatide (Compounded) Northwind Telehealth
Purity 97.4% Verified
Tirzepatide (Compounded) BioRegen Research
Purity 98.2% Verified

Latest Coverage

Community Discussions

Forum

The Peptide Institute Weekly

Research. Testing. Regulation. No hype.

One email a week: new study summaries, the latest independent lab results, ranking movements, and regulatory developments that matter.

  • New research, summarized in plain English
  • Independent lab results as they publish
  • Score and ranking movements